abbvie q2 2024 earnings

Latest Posts

Specialty biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) Thursday introduced second-quarter 2024 monetary outcomes, reporting...

Market

AbbVie Q2 2024 adj. revenue drops regardless of greater revenues; outcomes beat | AlphaStreet